Page 3 - norgine-annual-report-2016

Norgine employs over 1,000 people across its In 2016, Norgine continued to execute its
commercial, development and manufacturing three strategic priorities:
operations and manages all aspects of
Norgine is a leading European product development, production, marketing,
specialist pharmaceutical sales and supply.
company which has been
established for over 110 years. Norgine believes that high quality health

Norgine has a direct commercial outcomes are best achieved through Achieve double
constructive partnerships with commercial
presence in all major European partners, health services, health professionals digit growth
markets, Australia and and patients.
New Zealand.
Norgine’s Vision 2020 is intended to ensure
that Norgine brings transformative products
Vision 2020: systems and patients, that might not
which add value and benefits to healthcare

otherwise be available to patients in Europe.

Norgine is the ‘go to’ With its pan-European presence, fully Strengthen late

integrated business model and strong
European specialist partnering track record, Norgine is well placed stage pipeline
to realise Vision 2020.
pharma company

Be a dynamic
place to work

1 2